420 related articles for article (PubMed ID: 26578886)
21. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
22. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
24. Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta.
Uribe-San Martín R; Herrera-Molina R; Olavarría L; Ramírez G; von Bernhardi R
Neuroscience; 2009 Feb; 158(4):1338-47. PubMed ID: 19041694
[TBL] [Abstract][Full Text] [Related]
25. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
[TBL] [Abstract][Full Text] [Related]
27. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
Wang WY; Tan MS; Yu JT; Tan L
Ann Transl Med; 2015 Jun; 3(10):136. PubMed ID: 26207229
[TBL] [Abstract][Full Text] [Related]
28. Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia.
Cheng-Chung Wei J; Huang HC; Chen WJ; Huang CN; Peng CH; Lin CL
Eur J Pharmacol; 2016 Jan; 770():16-24. PubMed ID: 26643169
[TBL] [Abstract][Full Text] [Related]
29. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
[TBL] [Abstract][Full Text] [Related]
31. Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide.
Zhong L; Jiang X; Zhu Z; Qin H; Dinkins MB; Kong JN; Leanhart S; Wang R; Elsherbini A; Bieberich E; Zhao Y; Wang G
Glia; 2019 Mar; 67(3):498-511. PubMed ID: 30484906
[TBL] [Abstract][Full Text] [Related]
32. Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP_{244-C} and Abeta-neurotoxicity in hippocampal cultures.
Ramírez G; Rey S; von Bernhardi R
J Alzheimers Dis; 2008 Sep; 15(1):45-59. PubMed ID: 18780966
[TBL] [Abstract][Full Text] [Related]
33. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
34. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation.
Cherry JD; Olschowka JA; O'Banion MK
J Neuroinflammation; 2015 Nov; 12():203. PubMed ID: 26538310
[TBL] [Abstract][Full Text] [Related]
35. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
36. Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.
Walker DG; Lue LF; Beach TG; Tooyama I
Cells; 2019 Jul; 8(7):. PubMed ID: 31340569
[TBL] [Abstract][Full Text] [Related]
37. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
[TBL] [Abstract][Full Text] [Related]
38. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
39. Microglial Activation Results in Inhibition of TGF-β-Regulated Gene Expression.
Affram KO; Mitchell K; Symes AJ
J Mol Neurosci; 2017 Dec; 63(3-4):308-319. PubMed ID: 28983846
[TBL] [Abstract][Full Text] [Related]
40. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]